DCGI approves Regenerative Medical Services’ Chondron ACI cell therapy product

2017-04-17 09:26:03

Regenerative Medical Services’ Chondron ACI cell therapy product is indicated for use of articular cartilage defects of knee, ankle & shoulder joints.By Team ABLEThe Drug Controller General of India (DCGI) has granted authorization to Mumbai-based Regenerative Medical Services Regrow (RMS Regrow) to market India’s first  product, Chondron ACI.According to Regrow, Chondron ACI is indic

Read more

M3 Biotechnology receives funding from Alzheimer’s Drug Discovery Foundation for human trials

2017-04-17 09:23:46

As the first investor in M3 Biotechnology, the Alzheimer’s Drug Discovery Foundation (ADDF) helped validate the therapeutic potential of M3’s drug candidate for Alzheimer’s disease.By Team ABLEAs the first investor in M3 Biotechnology, the Alzheimer’s Drug Discovery Foundation (ADDF) helped validate the therapeutic potential of M3’s drug candidate for Alzheimer’s disease. With a second

Read more

Roche launches antibody test for diagnosis of challenging prostate cancer cases

2017-04-17 09:21:41

Roche\'s anti-p504s (SP116) Primary Antibody is a tool to aid clinicians in making a more accurate diagnosis with a smaller tissue sampleBy Team ABLERoche has announced the global launch of the anti-p504s (SP116) Rabbit Monoclonal Primary Antibody for prostate cancer diagnosis. This antibody has been validated for use in a dual stain with the VENTANA Basal Cell Cocktail (34ßE12+p63) to aid in dis

Read more

Dr V Mohan’s Diabetes Specialties Centre raises Rs 66 crore to further expand facilities in India

2017-04-13 07:17:10

Dr Mohan’s Diabetes Specialities Centre has raised a Series-A investment round of $10.23 million (Rs 66 crore) from Lok Capital and Evolvence India Fund By Team ABLEChennai-headquartered Diabetologist Dr V Mohan’s Diabetes Specialties Centre has raised Series-A investment round of $10.23 million (Rs 66 crore) from Lok Capital and Evolvence India Fund, a private equity fund. This has been noted

Read more

Union Minister J P Nadda reviews preparedness regarding Dengue and Chikungunya

2017-04-13 07:16:24

States asked to mount aggressive IEC campaigns for creating awareness on prevention & control of vectors By Team ABLEMr J P Nadda, Union Minister for Health and Family Welfare, held a high-level meeting to review the preparedness of the Ministry and Central Government Hospitals for prevention and control of dengue and chikungunya in the country. During the meeting, Mr Nadda asked the States fo

Read more

NIH scientists advance understanding of herpesvirus infection

2017-04-13 07:14:22

National Institutes of Health scientists have identified a set of protein complexes that are recruited to viral genes and stimulate both initial infection and reactivation from latency. By Team ABLEHerpes simplex virus (HSV) infections last a lifetime. Once a person has been infected, the virus can remain dormant (latent) for years before periodically reactivating to cause recurrent disease. This

Read more

Indian, Australian Prime Ministers inaugurate TERI-Deakin University’s joint Nano Biotechnology Research Centre in Gurgaon

2017-04-13 06:21:32

The TERI-Deakin Nano Biotechnology Centre (TDNBC), established at Gwal Pahari, Gurgaon, aims to support and nurture innovative ideas for existing problems of Indian agriculture amongst other sectors.By Team ABLEHon’ble Prime Minister Narendra Modi along with Australian Prime Minister Malcolm Turnbull, inaugurated the world’s most advanced nanobiotechnology research centre, a joint venture betw

Read more

GE Healthcare invests in Zenith Technologies, companies to co-deliver next-generation biopharma automation

2017-04-13 06:19:44

This partnership brings Zenith’s automation expertise to GE Healthcare’s customers, helping biopharmaceutical manufacturers to improve their product quality.By Team ABLEGE Healthcare Life Sciences has completed a strategic minority investment in Irish-owned Zenith Technologies, a company that delivers manufacturing software systems and solutions for the life sciences industry. This enhancement

Read more

Monoclonal antibody therapeutics market to be valued at $245.8 bn by 2024: Transparency Market Research report

2017-04-13 06:18:35

Transparency Market Research states that the global monoclonal antibody therapeutics market will expand at a favorable 12.6% CAGR from 2016 to 2024, rising from a valuation of US$86.7 bn in 2015 to US$245.8 bn by 2024.By Team ABLEUS-based Transparency Market Research (TMR) has recently launched a report on global monoclonal antibody therapeutics market. According to the report, the global monoclon

Read more

DBT, C-CAMP ink agreement with Finnish company to explore saliva-based oral cancer screening method

2017-04-12 06:35:34

DBT, C-CAMP and Aqsens Health have, with the support of Team Finland, launched a long-term collaboration project to validate and bring to market saliva based oral cancer screening methodBy Team ABLEOn April 10 2017, the Department of Biotechnology of India, Centre for Cellular and Molecular Platforms (C-CAMP) and Aqsens Health Pvt Ltd, with the support of Team Finland and other collaborating local

Read more